Thync announced on Oct. 8 that it had raised $13 million from investors to mine the intersection of neuroscience and consumer electronics. The company will began selling a Bluetooth enabled neurosignaling device sometime time next year. The device is a way to overcome our basic limitations as people enabling us to be focused, calm and creative when we need it. Thync is developing it as an alternative to mood-altering drugs such as alcohol or caffeine. Read More>>